|The KCNIP3 kcnip3 (Catalog #MBS611195) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The DREAM (Downstream Regulatory Element Antagonist Modulator, Calsenilin) reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s DREAM can be used in a range of immunoassay formats including, but not limited to, Western Blot (WB).
Suitable for use in Western Blot.
Dilution: Western Blot: 1:250-1:500. Researchers should empirically determine the suitability of the KCNIP3 kcnip3 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The KCNIP3 kcnip3 product has the following accession number(s) (GI #6006496) (Uniprot Accession #Q9Y2W7). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
The human prodynorphin gene, which is involved in memory acquisition and pain, is regulated by its downstream regulatory element (DRE), which acts as a location-dependent gene silencer. DREAM is a transcriptional repressor, DRE-antagonist modulator. It is the rst known Ca2+ binding protein that binds to DNA and regulates transcription.
Immunogen: Synthetic peptide, aa26-35 [SAPRTQPVKE] of the human DREAM protein. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing KCNIP3 are readily searchable from our website. Different antibodies against the same target such as KCNIP3 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. Breast Neoplasms, Carcinoma, Dementia, Drug Toxicity, Edema, Mental Disorders, Thyroid Diseases are some of the diseases may be linked to DREAM (Downstream Regulatory Element Antagonist Modulator, Calsenilin). Brain, Eye, Kidney, Thymus, Thyroid tissues are correlated with this protein. The following patways have been known to be associated with this gene. KCNIP3 also interacts with the following gene(s): CASP3, CREM, PSEN1, PSEN2.